Chirogate is a professional Prostaglandin manufacturer.
01 2Chirogate International Inc
02 2Nuray Chemicals Private Limited
03 1EUROAPI Hungary Ltd.
04 1Eurofins CDMO Alphora Inc
05 5MSN Laboratories Private Limited
06 1YS Life Science Co., Ltd.
01 2TREPROSTINIL SODIUM
02 4Treprostinil
03 5Treprostinil Sodium
04 1Treprostinil diethanolamine
01 2France
02 7India
03 1South Korea
04 2Taiwan
Chirogate is a professional Prostaglandin manufacturer.
NDC Package Code : 68245-0008
Start Marketing Date : 2010-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.
NDC Package Code : 58159-040
Start Marketing Date : 2016-06-14
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (35kg/35kg)
Marketing Category : BULK INGREDIENT
EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.
NDC Package Code : 82231-115
Start Marketing Date : 2019-11-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Chirogate is a professional Prostaglandin manufacturer.
NDC Package Code : 68245-0009
Start Marketing Date : 2010-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.
NDC Package Code : 58159-041
Start Marketing Date : 2016-07-25
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (35kg/35kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 43076-001
Start Marketing Date : 2019-03-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 14501-0015
Start Marketing Date : 2014-08-25
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 14501-0016
Start Marketing Date : 2014-08-25
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 14501-0017
Start Marketing Date : 2014-08-25
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 40016-009
Start Marketing Date : 2012-05-30
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
A Remodulin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Remodulin, including repackagers and relabelers. The FDA regulates Remodulin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Remodulin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Remodulin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Remodulin supplier is an individual or a company that provides Remodulin active pharmaceutical ingredient (API) or Remodulin finished formulations upon request. The Remodulin suppliers may include Remodulin API manufacturers, exporters, distributors and traders.
click here to find a list of Remodulin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Remodulin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Remodulin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Remodulin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Remodulin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Remodulin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Remodulin suppliers with NDC on PharmaCompass.
We have 6 companies offering Remodulin
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
